Login / Signup

Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort.

Yi MiaoYeqin ShaYi XiaShuchao QinRui JiangLuomengjia DaiHui ShenTonglu QiuWei WuJingyan QiuYilian YangChongyang DingYujie WuLei FanWei XuJian-Yong LiHuayuan Zhu
Published in: Blood cancer journal (2023)
Keyphrases
  • chronic lymphocytic leukemia
  • low dose
  • acute myeloid leukemia
  • bone marrow
  • high dose
  • copy number
  • diffuse large b cell lymphoma
  • dna methylation
  • gene expression
  • smoking cessation
  • hodgkin lymphoma